Release Date: 11/03/21 10:10 Summary: FY21 Half Year Report and Accounts with commentary Price Sensitive: Yes Download Document 3.38MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago